kalshi
Financials
FDA decision: Rusfertide by Protagonist Therapeutics (in 2026)
0 outcomes · Closes — · 24h volume —
Outcomes & current odds
Summary
SourceKalshi
Outcomes0
Total 24h volume—
Closes—